Obizur (Antihemophilic factor [Recombinant], porcine sequence) for Hemophilia

Overview
Obizur is approved by the Food and Drug Administration (FDA) to control bleeding episodes in adults with acquired hemophilia. The technical name of Obizur is Antihemophilic factor (recombinant), porcine sequence.

How do I take it?
Prescribing information states that Obizur is given as an intravenous injection.

Obizur comes as a powder that must be reconstituted before injection.

Side effects
The FDA-approved label for Obizur lists common side effects including the development of inhibitors.

For more details about this treatment, visit:

Obizur prescribing information (PDF) – Baxalta.com

Treatment of Hemophilia – Hemophilia Federation of America